FILTER

Refine your search with the following facets to narrow down your results.

3 Current news of mallia-therapeutics

image description

16th BioVaria honours SurvivX and QUASAR Therapeutics with Startup Pitch & Partner Awards

Among the GO-Bio initial and ForTra projects, Innovade, Cognisa and Mallia Therapeutics were selected as winners

07-May-2024 - The international life-science community gathered last week in Munich for the 16th BioVaria, Europe’s leading showcasing event for breakthrough technologies and start-ups in the field. Organized by 13 technology transfer organizations, the event serves as a catalyst for forging partnerships ...

sepsis start-ups
image description

Novel Topical Treatment to Induce Hair Growth via Immune Modulation

Mallia Therapeutics Secures Seed Funding

19-Jul-2023 - Mallia Therapeutics GmbH, a biopharmaceutical company developing soluble CD83 (sCD83) for the treatment of hair loss, announced that the newly founded company secured its seed financing. The Company plans to develop the sCD83 candidate based on preclinical and ex vivo human data, presented at the ...

alopecia hair hair loss +4
image description

Pioneering research projects at the 8th Life Science Pitch Day at the IZB

A total of sixteen teams presented their innovative ideas to almost 50 investors at the Munich start-up center.

18-Jul-2023 - On July 13, 2023, the Munich Innovation and Start-up Center for Biotechnology (IZB) organized the 8th Life Science Pitch Day in cooperation with High-Tech Gründerfonds (HTGF), Leaps by Bayer, and Boehringer Ingelheim, which brought together sixteen biotech start-ups and project teams and almost ...

antibiotics artificial intelligence autoimmune diseases +10